logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Ruey-Long Hong

national taiwan university
H指数:41
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nanoliposomal Irinotecan in Combination With 5-Fluorouracil and Leucovorin for Advanced Head and Neck and Esophageal Squamous Cell Carcinoma After Prior Platinum-Based Chemotherapy or Chemoradiotherapy: A Multicenter Phase II Trial

纳米脂质体伊立替康联合5-氟尿嘧啶和亚叶酸钙用于经前期铂类为基础的化疗或放化疗后的晚期头颈及食管鳞状细胞癌：一项多中心II期临床试验

Cancer Medicine
IF3.1
2025-10-210
OAAI
Muh-Hwa Yang; Shang-Yin Wu; I-Wei Ho; Nai-Jung Chiang; Chin-Fu Hsaio; Chen-Yuan Lin; Ming-Yu Lien; Peter Mu-Hsin Chang; Jia-Hong Chen; Ching-Yun Hsieh; Ruey-Long Hong; Chao-Tung Lee; Li-Tzong Chen; Tsang-Wu Liu; Chang-Fang Chiu; Li-Yuan Bai
Sequential multimodal treatments with chemotherapy and surgery for advanced soft tissue sarcoma may be associated with better survival than chemotherapy

对于晚期软组织肉瘤，采用化疗联合手术的序贯多模式治疗，可能比单独化疗具有更好的生存率。

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
IF2.5
2025-01-011
OAAI
Chen, Ching-Tso; Chen, Hsing-Wu; Lin, Wei-Hsin; Huang, Pei-Ming; Lin, Mong-Wei; Yang, Ching-Yao; Hsu, Che-Yu; Wang, Chia-Chun; Lee, Jen-Chieh; Chang, Koping; Huang, Kuo-Hao; Chen, Ho-Min; Chen, Tom Wei-Wu; Yang, Rong-Sen; Hong, Ruey-Long
Lifetime measurements of the first 2+ states in 116,118Te
PHYSICAL REVIEW C
IF3.4
2024-03-151
PRE
Li, C. B.; Zheng, Y.; Li, T. X.; Wu, X. G.; Wu, H. Y.; Zheng, M.; Zhao, Z. H.; Li, Y. Q.; Hong, R.; He, Z. Y.; Li, J. Z.; Wang, J. L.; Guo, C. Y.; Zhou, Z. X.; Ni, L.; Li, G. S.; Zhou, X. H.; Guo, B.; Wang, S. Y.; Liu, M. L.; Zhang, Y. H.; He, C. Y.; Liu, F. L.; Wang, S.; Zhu, L. H.
A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Alpelisib联合西妥昔单抗治疗复发或转移性头颈部鳞状细胞癌的1b/2期研究

TARGETED ONCOLOGY
IF4
2023-10-257
OAAI
Razak, Albiruni R. Abdul; Wang, Hung-Ming; Chang, Jang-Yang; Ahn, Myung-Ju; Munster, Pamela; Blumenschein Jr, George; Solomon, Benjamin; Lim, Darren Wan-Teck; Hong, Ruey-Long; Pfister, David; Saba, Nabil F.; Lee, Se-Hoon; van Herpen, Carla; Quadt, Cornelia; Bootle, Douglas; Blumenstein, Lars; Demanse, David; Delord, Jean-Pierre
Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma
NATURE COMMUNICATIONS
IF15.7
2023-05-1511
OAAI
Lim, Darren Wan-Teck; Kao, Hsiang-Fong; Suteja, Lisda; Li, Constance H.; Quah, Hong Sheng; Tan, Daniel Shao-Weng; Tan, Sze-Huey; Tan, Eng-Huat; Tan, Wan-Ling; Lee, Justina Nadia; Wee, Felicia Yu-Ting; Jain, Amit; Goh, Boon-Cher; Chua, Melvin L. K.; Liao, Bin-Chi; Ng, Quan Sing; Hong, Ruey-Long; Ang, Mei-Kim; Yeong, Joe Poh-Sheng; Iyer, N. Gopalakrishna
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
ORAL ONCOLOGY
IF3.9
2022-05-0121
OAAI
Rischin, Danny; Harrington, Kevin J.; Greil, Richard; Soulieres, Denis; Tahara, Makoto; de Castro Jr, Gilberto; Psyrri, Amanda; Brana, Irene; Neupane, Prakash; Bratland, Ase; Fuereder, Thorsten; Hughes, Brett G. M.; Mesia, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Hong, Ruey-Long; Mendoza, Rene Gonzalez; Jia, Liyi; Chirovsky, Diana; Norquist, Josephine; Jin, Fan; Burtness, Barbara
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

单用派姆单抗或联合化疗与西妥昔单抗联合化疗治疗头颈部复发或转移性鳞状细胞癌 (KEYNOTE-048): 一项随机、开放标签、3期研究

LANCET
IF88.5
2019-11-012.0K
OAAI
Burtness, Barbara; Harrington, Kevin J.; Greil, Richard; Soulieres, Denis; Tahara, Makoto; de Castro, Gilberto, Jr.; Psyrri, Amanda; Baste, Neus; Neupane, Prakash; Bratland, Ase; Fuereder, Thorsten; Hughes, Brett G. M.; Mesia, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Hong, Ruey-Long; Mendoza, Rene Gonzalez; Roy, Ananya; Zhang, Yayan; Gumuscu, Burak; Cheng, Jonathan D.; Jin, Fan; Rischin, Danny

研究方向

暂未获取到该数据
J
Jo‐Pai Chen
H 指数:5论文数:42被引数:76
J
Jui-Ying Chang
H 指数:1论文数:28被引数:1
N
N. Nasr
H 指数:3论文数:34被引数:28
S
Sung‐Hsin Kuo
H 指数:43论文数:382被引数:6,083
L
Lai‐Lei Ting
H 指数:24论文数:98被引数:1,684
D
D. McRae
H 指数:12论文数:47被引数:534
J
Jenq‐Yuh Ko
H 指数:35论文数:165被引数:3,631
R
Robert R. Kuske
H 指数:48论文数:238被引数:8,325
C
C.A. Mantz
H 指数:22论文数:152被引数:2,374
S
S.E. Finkelstein
H 指数:4论文数:100被引数:102